Anti-IL-6 Antibody
Inflammatory/Autoimmune Diseases (via selective trans-signaling inhibition)
Pre-clinicalActive
Key Facts
Indication
Inflammatory/Autoimmune Diseases (via selective trans-signaling inhibition)
Phase
Pre-clinical
Status
Active
Company
About MAB Designs
MAB Designs is a privately-held, pre-clinical stage biotech company developing conformation-selective antibodies. Its lead program is a humanized IgG1 antibody designed to uniquely block IL-6 trans-signaling while sparing classical signaling, a novel approach that could expand therapeutic applications beyond current IL-6 inhibitors. Founded and led by industry veterans, the company is internally funded, holds key patents, and operates with a lean structure while seeking partnerships to advance its pipeline.
View full company profile